BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19484986)

  • 1. [Clinical analysis of 20 adults esthesioneuroblastoma with combined therapy].
    Li JS; Xie FY; Peng M; Han F
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 44(1):36-9. PubMed ID: 19484986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
    de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
    Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esthesioneuroblastoma: the Northwestern University experience.
    Argiris A; Dutra J; Tseke P; Haines K
    Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 34 cases of esthesioneuroblastoma].
    Liu WS; Tang PZ; Xu GZ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
    Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 53 cases of esthesioneuroblastoma].
    Chen YF; Yang AK; Zhang Q; Ouyang D; Chen WK; Chen FJ
    Ai Zheng; 2009 Mar; 28(3):308-11. PubMed ID: 19619448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.
    Diaz EM; Johnigan RH; Pero C; El-Naggar AK; Roberts DB; Barker JL; DeMonte F
    Head Neck; 2005 Feb; 27(2):138-49. PubMed ID: 15654688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.
    Jethanamest D; Morris LG; Sikora AG; Kutler DI
    Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):276-80. PubMed ID: 17372086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review.
    El Kababri M; Habrand JL; Valteau-Couanet D; Gaspar N; Dufour C; Oberlin O
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):91-5. PubMed ID: 24390450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined modality therapy of esthesioneuroblastoma.
    McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esthesioneuroblastoma: the University of Iowa experience 1978-1998.
    Simon JH; Zhen W; McCulloch TM; Hoffman HT; Paulino AC; Mayr NA; Buatti JM
    Laryngoscope; 2001 Mar; 111(3):488-93. PubMed ID: 11224781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
    Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
    Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleomorphic olfactory neuroblastoma (esthesioneuroblastoma): histopathological findings and clinical course.
    Emerson LL; Layfield LJ; Frame R
    Histopathology; 2007 Sep; 51(3):430-2. PubMed ID: 17727493
    [No Abstract]   [Full Text] [Related]  

  • 17. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
    Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
    Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
    Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of esthesioneuroblastoma.
    Zhang M; Zhou L; Wang DH; Huang WT; Wang SY
    ORL J Otorhinolaryngol Relat Spec; 2010; 72(2):113-8. PubMed ID: 20453548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cystic adenoid carcinomas (cylindromas) and olfactory esthesio-neuromas of the nasal cavities and paranasal sinuses. Experience of the ORL Group of the National Federation of Cancer Centers].
    Schwaab G; Lefebvre JL; Julieron M
    Neurochirurgie; 1997; 43(2):118-20. PubMed ID: 9296055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.